Borgen PI - Search Results

1

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.

Kauff ND, Brogi E, Scheuer L, Pathak DR, Borgen PI, Hudis CA, Offit K, Robson ME. Kauff ND, et al. Among authors: borgen pi. Cancer. 2003 Apr 1;97(7):1601-8. doi: 10.1002/cncr.11225. Cancer. 2003. PMID: 12655515 Free article.

2

Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.

King TA, Gemignani ML, Li W, Giri DD, Panageas KS, Bogomolniy F, Arroyo C, Olvera N, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Among authors: borgen pi. Cancer Res. 2004 Aug 1;64(15):5051-3. doi: 10.1158/0008-5472.CAN-04-1283. Cancer Res. 2004. PMID: 15289302

3

Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.

King TA, Ganaraj A, Fey JV, Tan LK, Hudis C, Norton L, Cody HS 3rd, Borgen PI. King TA, et al. Among authors: borgen pi. Cancer. 2004 Sep 1;101(5):926-33. doi: 10.1002/cncr.20517. Cancer. 2004. PMID: 15329899 Free article.

4

A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.

Kattan MW, Giri D, Panageas KS, Hummer A, Cranor M, Van Zee KJ, Hudis CA, Norton L, Borgen PI, Tan LK. Kattan MW, et al. Among authors: borgen pi. Cancer. 2004 Dec 1;101(11):2509-15. doi: 10.1002/cncr.20635. Cancer. 2004. PMID: 15495180 Free article.

5

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K. Kauff ND, et al. Among authors: borgen pi. J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4. doi: 10.1093/jnci/dji281. J Natl Cancer Inst. 2005. PMID: 16174860

6

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Among authors: borgen pi. Ann Surg Oncol. 2007 Sep;14(9):2510-8. doi: 10.1245/s10434-007-9372-1. Epub 2007 Jun 29. Ann Surg Oncol. 2007. PMID: 17597348

7

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. Kauff ND, et al. Among authors: borgen pi. N Engl J Med. 2002 May 23;346(21):1609-15. doi: 10.1056/NEJMoa020119. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023992 Free article.

8

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Scheuer L, et al. J Clin Oncol. 2002 Mar 1;20(5):1260-8. doi: 10.1200/JCO.2002.20.5.1260. J Clin Oncol. 2002. PMID: 11870168

9

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.

Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L, Offit K. Robson M, et al. Cancer. 2005 Jan 1;103(1):44-51. doi: 10.1002/cncr.20728. Cancer. 2005. PMID: 15558796 Free article.

10

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page